AKRO

Akero Therapeutics Stock Price

26.24
0.43 (1.67%)
Upgrade to Real-Time
Afterhours (Closed)
26.24
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Akero Therapeutics Inc AKRO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.43 1.67% 26.24 20:00:00
Close Price Low Price High Price Open Price Previous Close
26.24 25.74 26.4699 26.04 25.81
Bid Price Ask Price Spread News
25.99 36.70 10.71 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,708 115,116 $ 26.17 $ 3,012,653 202,706 10.78 - 41.89
Last Trade Time Type Quantity Stock Price Currency
16:34:56 1 $ 38.10 USD

Akero Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 910.55M 34.70M 19.02M $ - $ - -3.21 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 415.00k 2.70%

more financials information »

Akero Therapeutics News

Date Time Source News Article
10/21/202016:05PR Newswire (US)Akero Therapeutics To Present At Upcoming Conferences In..
10/16/202007:30PR Newswire (US)Akero Therapeutics Receives European Medicines Agency..
10/15/202008:32Edgar (US Regulatory)Current Report Filing (8-k)
10/02/202007:30PR Newswire (US)Akero Therapeutics To Present Data From Phase 2a BALANCED..
9/30/202008:00PR Newswire (US)Akero Therapeutics Completes Enrollment of Cohort of..
9/28/202016:05PR Newswire (US)Akero Therapeutics to Present at H.C. Wainwright's 4th..
9/24/202007:30PR Newswire (US)Akero Therapeutics To Continue Efruxifermin Development With..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AKRO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week27.9629.3725.49527.00222,461-1.72-6.15%
1 Month32.5432.8125.49528.73194,971-6.30-19.36%
3 Months36.1237.9425.49532.58182,658-9.88-27.35%
6 Months19.4441.8918.3631.59268,0166.8034.98%
1 Year20.9241.8910.7827.57218,6955.3225.43%
3 Years16.1641.8910.7826.63193,41110.0862.38%
5 Years16.1641.8910.7826.63193,41110.0862.38%

Akero Therapeutics Description

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate AKR-001 is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
Your Recent History
NASDAQ
AKRO
Akero Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201024 18:45:44